The evolutionary history of 2,658 cancers
暂无分享,去创建一个
Benjamin J. Raphael | Salem Malikic | Martin Peifer | Kortine Kleinheinz | Jonas Demeulemeester | Ignaty Leshchiner | Dimitri G. Livitz | Peter Van Loo | Yuan Ji | Gad Getz | Yu Fan | S. Cenk Sahinalp | Ke Yuan | Florian Markowetz | Marcin Imielinski | Yulia Rubanova | Kerstin Haase | Maxime Tarabichi | Geoff Macintyre | Jeff Wintersinger | Xiaotong Yao | Rameen Beroukhim | Hongtu Zhu | Moritz Gerstung | Amit Deshwar | Thomas J. Mitchell | Paul C. Boutros | Subhajit Sengupta | Marek Cmero | Clemency Jolly | Stefan C. Dentro | Santiago Gonzalez | Daniel Rosebrock | Pavana Anur | Kaixian Yu | Ignacio Vázquez-García | Lara Jerman | Nilgun Donmez | Steven Schumacher | Juhee Lee | Matthias Schlesner | David D. Bowtell | Ville Mustonen | Wenyi Wang | Quaid D. Morris | Paul T. Spellman | David C. Wedge | F. Markowetz | P. Spellman | G. Getz | R. Eils | Q. Morris | R. Beroukhim | S. C. Sahinalp | P. Boutros | D. Bowtell | Nilgun Donmez | P. Loo | D. Wedge | G. Ha | M. Imieliński | M. Gerstung | I. Martincorena | Ville Mustonen | M. Schlesner | S. Schumacher | Shankar Vembu | Yuan Ji | S. Cao | Yulia Rubanova | Santiago Gonzalez | Pavana Anur | Myron Peto | M. Peifer | K. Dawson | K. Haase | D. Rosebrock | D. Livitz | I. Leshchiner | Layla Oesper | K. Kleinheinz | Subhajit Sengupta | T. Mitchell | J. Demeulemeester | Ke Yuan | S. Malikić | G. Macintyre | Marek Cmero | S. Dentro | M. Tarabichi | J. Wintersinger | A. Deshwar | Kaixian Yu | Clemency Jolly | Yu Fan | M. Fittall | Ruben M. Drews | Juhee Lee | Hongtu Zhu | Wenyi Wang | A. Salcedo | H. Lee-Six | E. Christie | Yupeng Cun | Lara Jerman | Ruian Shi | O. Spiro | Xiaotong Yao | D. J. Adams | I. Vázquez-García | Tsun-Po Yang | David A. Wheeler | Lincoln D. Stein | Peter J. Campbell | Seung Jun Shin | D. W. Garsed | Lincoln Stein | Q. Morris | Peter J. Campbell
[1] B. Taylor,et al. deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution , 2016, Genome Biology.
[2] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[3] G. Getz,et al. The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis , 2016, Nature Genetics.
[4] Kenta Hongo,et al. !"# $%&'( , 2018, GIS.
[5] Angelika Amon,et al. Single-chromosome Gains Commonly Function as Tumor Suppressors. , 2017, Cancer cell.
[6] Shelley Tworoger,et al. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. , 2008, Gynecologic oncology.
[7] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[8] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[9] Giovanni Parmigiani,et al. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation , 2013, Proceedings of the National Academy of Sciences.
[10] M. Nykter,et al. The Evolutionary History of Lethal Metastatic Prostate Cancer , 2015, Nature.
[11] Jun Yu,et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes , 2020, Nature.
[12] Paul T. Spellman,et al. Methods and challenges in timing chromosomal abnormalities within cancer samples , 2013, Bioinform..
[13] Nicolai J. Birkbak,et al. Tracking the Evolution of Non‐Small‐Cell Lung Cancer , 2017, The New England journal of medicine.
[14] P. Lønning,et al. Genomic Evolution of Breast Cancer Metastasis and Relapse , 2017, Cancer cell.
[15] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[16] Robert T. Jones,et al. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. , 2015, Cancer discovery.
[17] Mario Cazzola,et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.
[18] Gary D. Bader,et al. Divergent clonal selection dominates medulloblastoma at recurrence , 2016, Nature.
[19] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[20] L. Salford,et al. Trisomy 7 and sex chromosome loss in human brain tissue. , 1989, Cytogenetics and cell genetics.
[21] M. Stratton,et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. , 2013, Blood.
[22] John Cairns,et al. Mutation selection and the natural history of cancer , 1975, Nature.
[23] Joshua F. McMichael,et al. Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.
[24] S. Luo,et al. High prevalence of focal and multi-focal somatic genetic variants in the human brain , 2018, Nature Communications.
[25] Yuan Ji,et al. Portraits of genetic intra-tumour heterogeneity and subclonal selection across cancer types , 2018, bioRxiv.
[26] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[27] Jian Li,et al. Temporal dissection of tumorigenesis in primary cancers. , 2011, Cancer discovery.
[28] T. Rohan,et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. , 2003, Journal of the National Cancer Institute.
[29] S. Gabriel,et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.
[30] G. Getz,et al. The whole-genome panorama of cancer drivers , 2017, bioRxiv.
[31] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[32] P. Campbell,et al. Somatic mutation in cancer and normal cells , 2015, Science.
[33] Amar S. Ahmad,et al. Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960 , 2015, British Journal of Cancer.
[34] Funda Meric-Bernstam,et al. Punctuated Copy Number Evolution and Clonal Stasis in Triple-Negative Breast Cancer , 2016, Nature Genetics.
[35] Hans Clevers,et al. Tissue-specific mutation accumulation in human adult stem cells during life , 2016, Nature.
[36] E. Klein,et al. High-Grade Prostatic Intraepithelial Neoplasia , 2012, Korean journal of urology.
[37] David Pellman,et al. A Mechanism Linking Extra Centrosomes to Chromosomal Instability , 2009, Nature.
[38] V. Siskind,et al. Ovulation and risk of epithelial ovarian cancer , 2003, International journal of cancer.
[39] Peter J. Campbell,et al. Somatic mutant clones colonize the human esophagus with age , 2018, Science.
[40] G. Falk,et al. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. , 2015, Gastroenterology clinics of North America.
[41] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[42] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[43] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[44] Joshy George,et al. Whole–genome characterization of chemoresistant ovarian cancer , 2015, Nature.
[45] Peter J. Campbell,et al. Population dynamics of normal human blood inferred from somatic mutations , 2018, Nature.
[46] A. Gazdar,et al. Preneoplasia of lung cancer. , 2010, Cancer biomarkers : section A of Disease markers.
[47] P. Van Loo,et al. Timing somatic events in the evolution of cancer , 2018, Genome Biology.
[48] S. Tsunoda,et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers , 2019, Nature.
[49] Martin A. Nowak,et al. Mutations driving CLL and their evolution in progression and relapse , 2015, Nature.
[50] Ville Mustonen,et al. The repertoire of mutational signatures in human cancer , 2018, Nature.
[51] H. Brenner,et al. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies , 2007, Gut.
[52] M. Thun,et al. Tobacco use and cancer: an epidemiologic perspective for geneticists , 2002, Oncogene.
[53] The landscape of somatic mutation in normal colorectal epithelial cells , 2019, Nature.
[54] Andrew Menzies,et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing , 2015, Nature Medicine.
[55] P. A. Futreal,et al. Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal , 2018, Cell.
[56] M. Stratton,et al. Clock-like mutational processes in human somatic cells , 2015, Nature Genetics.
[57] R. DePinho,et al. Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.
[58] Joshua F. McMichael,et al. Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing , 2011, Nature.
[59] W. Dupont,et al. The natural history of low‐grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long‐term follow‐up , 2005, Cancer.
[60] Chris Sander,et al. Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.
[61] M. Stratton,et al. High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.
[62] Icgc,et al. Pan-cancer analysis of whole genomes , 2017, bioRxiv.
[63] Nicolai J. Birkbak,et al. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution , 2015, Science Translational Medicine.
[64] Ville Mustonen,et al. The evolutionary landscape of colorectal tumorigenesis , 2018, Nature Ecology & Evolution.
[65] M. Stratton,et al. The mutational landscape of normal human endometrial epithelium , 2018, bioRxiv.
[66] Joshua F. McMichael,et al. The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.
[67] P. A. Futreal,et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing , 2014, Nature Genetics.